Bacterial lipopolysaccharide and antimicrobial LL-37 enhance ICAM-1 expression and NF-κB p65 phosphorylation in senescent endothelial cells

Suzuki,Kaori; Ohkuma,Mari; Nagaoka,Isao

doi:10.3892/ijmm.2019.4294

Bacterial lipopolysaccharide and antimicrobial LL-37 enhance ICAM-1 expression and NF-κB p65 phosphorylation in senescent endothelial cells

Authors:
- Kaori Suzuki
- Mari Ohkuma
- Isao Nagaoka
View Affiliations

Affiliations: Department of Host Defense and Biochemical Research, Juntendo University Graduate School of Medicine, Tokyo 113‑8421, Japan
Published online on: July 31, 2019 https://doi.org/10.3892/ijmm.2019.4294
Pages: 1187-1196
Copyright: © Suzuki et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cellular senescence is associated with the induction of a proinflammatory phenotype. Notably, senescent endothelial cells are detected at the sites of atherosclerotic lesions, suggesting the involvement of senescent endothelial cells in atherogenesis. Moreover, bacterial infection has been speculated to contribute to the pathogenesis of atherosclerosis. The present study investigated the effects of Gram‑negative bacterial lipopolysaccharide (LPS) and LL‑37 (a human antimicrobial peptide of the cathelicidin family), on senescent endothelial cells, using serially passaged human endothelial cells. The results indicated that senescent endothelial cells exhibited the basal proinflammatory phenotype, as evidenced by higher intercellular adhesion molecule‑1 (ICAM‑1) expression and NF‑κB p65 phosphorylation, compared with non‑senescent cells. Additionally, exposure to LPS and LL‑37 further enhanced the expression of ICAM‑1 in senescent endothelial cells, compared with non‑senescent cells. Of note, the NF‑κB p65 pathway was more activated in senescent endothelial cells stimulated with LPS and LL‑37. Furthermore, the expression levels of the receptors for LPS and LL‑37 [toll‑like receptor 4 (TLR4) and purinergic receptor P2X 7 (P2X7), respectively] were upregulated in senescent endothelial cells. These observations indicated that LPS and LL‑37 enhanced the ICAM‑1 expression and NF‑κB p65 activation in senescent endothelial cells, potentially via the upregulated TLR4 and P2X7. Thus, senescent endothelial cells may contribute to the pathogenesis of atherosclerosis via the basal proinflammatory phenotype and the enhanced inflammatory responses against atherogenic factors, including LPS and LL‑37.

View Figures

View References

1	Hayflick L: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 37:614–636. 1965. View Article : Google Scholar : PubMed/NCBI
2	Coppé JP, Desprez PY, Krtolica A and Campisi J: The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu Rev Pathol. 5:99–118. 2010. View Article : Google Scholar : PubMed/NCBI
3	Campisi J and d'Adda di Fagagna F: Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol. 8:729–740. 2007. View Article : Google Scholar : PubMed/NCBI
4	Childs BG, Durik M, Baker DJ and van Deursen JM: Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nat Med. 21:1424–1435. 2015. View Article : Google Scholar : PubMed/NCBI
5	Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H and Komuro I: Endothelial cell senescence in human atherosclerosis: Role of telomere in endothelial dysfunction. Circulation. 105:1541–1544. 2002. View Article : Google Scholar : PubMed/NCBI
6	Aimetti M, Romano F and Nessi F: Microbiologic analysis of periodontal pockets and carotid atheromatous plaques in advanced chronic periodontitis patients. J Periodontol. 78:1718–1723. 2007. View Article : Google Scholar : PubMed/NCBI
7	Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J and Salomaa V: Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol. 27:1433–1439. 2007. View Article : Google Scholar : PubMed/NCBI
8	Edfeldt K, Swedenborg J, Hansson GK and Yan ZQ: Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation. 105:1158–1161. 2002. View Article : Google Scholar : PubMed/NCBI
9	Nagaoka I, Hirata M, Sugimoto K, Tsutsumi-Ishii Y, Someya A, Saionji K and Igari J: Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow. J Leukoc Biol. 64:845–852. 1998. View Article : Google Scholar : PubMed/NCBI
10	Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ and Tack BF: Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun. 68:2748–2755. 2000. View Article : Google Scholar : PubMed/NCBI
11	Choi KY, Chow LNY and Mookherjee N: Cationic host defence peptides: Multifaceted role in immune modulation and inflammation. J Innate Immun. 4:361–370. 2012.PubMed/NCBI
12	Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrücker K, Unterberger P, Zaiou M, Lebherz C, et al: An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 111:1665–1672. 2003. View Article : Google Scholar : PubMed/NCBI
13	Byfield FJ, Wen Q, Leszczynska K, Kulakowska A, Namiot Z, Janmey PA and Bucki R: Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability. Am J Physiol Cell Physiol. 300:C105–C112. 2011. View Article : Google Scholar :
14	Edfeldt K, Agerberth B, Rottenberg ME, Gudmundsson GH, Wang XB, Mandal K, Xu Q and Yan ZQ: Involvement of the antimicrobial peptide LL-37 in human atherosclerosis. Arterioscler Thromb Vasc Biol. 26:1551–1557. 2006. View Article : Google Scholar : PubMed/NCBI
15	Doering Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, Vijayan S, Gallo RL, Weber C and Soehnlein O: Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res. 110:1052–1056. 2012. View Article : Google Scholar
16	Wantha S, Alard JE, Megens RT, van der Döes AM, Döring Y, Drechsler M, Pham CT, Wang MW, Wang JM, Gallo RL, et al: Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res. 112:792–801. 2013. View Article : Google Scholar : PubMed/NCBI
17	Mihailovic PM, Lio WM, Yano J, Zhao X, Zhou J, Chyu KY, Shah PK, Cercek B and Dimayuga PC: The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(−/−) mice. PLoS One. 12:e01874322017. View Article : Google Scholar
18	Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, Premsrirut P, Luo W, Chicas A, Lee CS, et al: Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 25:2125–2136. 2011. View Article : Google Scholar : PubMed/NCBI
19	Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H and Heumann D: Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol. 167:3329–3338. 2001. View Article : Google Scholar : PubMed/NCBI
20	Yanaka M, Honma T, Sato K, Shinohara N, Ito J, Tanaka Y, Tsuduki T and Ikeda I: Increased monocytic adhesion by senescence in human umbilical vein endothelial cells. Biosci Biotechnol Biochem. 75:1098–1103. 2011. View Article : Google Scholar : PubMed/NCBI
21	Dauphinee SM and Karsan A: Lipopolysaccharide signaling in endothelial cells. Lab Invest. 86:9–22. 2006. View Article : Google Scholar
22	Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J and Sambhara S: Cutting edge: Impaired Toll-like receptor expression and function in aging. J Immunol. 169:4697–4701. 2002. View Article : Google Scholar : PubMed/NCBI
23	Qian F, Wang X, Zhang L, Chen S, Piecychna M, Allore H, Bockenstedt L, Malawista S, Bucala R, Shaw AC, et al: Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell. 11:104–110. 2012. View Article : Google Scholar :
24	Berkestedt I, Nelson A and Bodelsson M: Endogenous antimicrobial peptide LL-37 induces human vasodilatation. Br J Anaesth. 100:803–809. 2008. View Article : Google Scholar : PubMed/NCBI
25	Nagaoka I, Tamura H and Hirata M: An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol. 176:3044–3052. 2006. View Article : Google Scholar : PubMed/NCBI
26	Khan SY, Awad EM, Oszwald A, Mayr M, Yin X, Waltenberger B, Stuppner H, Lipovac M, Uhrin P and Breuss JM: Premature senescence of endothelial cells upon chronic exposure to TNFα can be prevented by N-acetyl cysteine and plumericin. Sci Rep. 7:395012017. View Article : Google Scholar
27	Tilstra JS, Clauson CL, Niedernhofer LJ and Robbins PD: NF-κB in aging and disease. Aging Dis. 2:449–465. 2011.
28	Ogura N, Matsuda U, Tanaka F, Shibata Y, Takiguchi H and Abiko Y: In vitro senescence enhances IL-6 production in human gingival fibroblasts induced by lipopolysaccharide from Campylobacter rectus. Mech Ageing Dev. 87:47–59. 1996. View Article : Google Scholar : PubMed/NCBI
29	Mochizuki K, Yamaguchi M and Abiko Y: Enhancement of LPS-stimulated plasminogen activator production in aged gingival fibroblasts. J Periodontal Res. 34:251–260. 1999. View Article : Google Scholar : PubMed/NCBI
30	Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB and Arditi M: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA. 101:10679–10684. 2004. View Article : Google Scholar : PubMed/NCBI
31	Lloyd-Jones KL, Kelly MM and Kubes P: Varying importance of soluble and membrane CD14 in endothelial detection of lipopoly-saccharide. J Immunol. 181:1446–1453. 2008. View Article : Google Scholar : PubMed/NCBI
32	Wang L, Wang J, Fang J, Zhou H, Liu X and Su SB: High glucose induces and activates Toll-like receptor 4 in endothelial cells of diabetic retinopathy. Diabetol Metab Syndr. 7:892015. View Article : Google Scholar : PubMed/NCBI
33	Nagyoszi P, Wilhelm I, Farkas AE, Fazakas C, Dung NT, Haskó J and Krizbai IA: Expression and regulation of toll-like receptors in cerebral endothelial cells. Neurochem Int. 57:556–564. 2010. View Article : Google Scholar : PubMed/NCBI
34	Borel N, Pospischil A, Dowling RD, Dumrese C, Gaydos CA, Bunk S, Hermann C, Ramirez JA and Summersgill JT: Antigens of persistent Chlamydia pneumoniae within coronary atheroma from patients undergoing heart transplantation. J Clin Pathol. 65:171–177. 2012. View Article : Google Scholar
35	Tsutsumi-Ishii Y, Shimada K, Daida H, Toman R and Nagaoka I: Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein. Int Immunol. 20:199–208. 2008. View Article : Google Scholar
36	An N, Andrukhov O, Tang Y, Falkensammer F, Bantleon HP, Ouyang X and Rausch-Fan X: Effect of nicotine and Porphyromonas gingivalis lipopolysaccharide on endothelial cells in vitro. PLoS One. 9:e969422014. View Article : Google Scholar : PubMed/NCBI
37	Carnevale R, Nocella C, Petrozza V, Cammisotto V, Pacini L, Sorrentino V, Martinelli O, Irace L, Sciarretta S, Frati G, et al: Localization of lipopolysaccharide from Escherichia coli into human atherosclerotic plaque. Sci Rep. 8:35982018. View Article : Google Scholar : PubMed/NCBI
38	Agier J, Efenberger M and Brzezińska-Blaszczyk E: Cathelicidin impact on inflammatory cells. Cent Eur J Immunol. 40:225–235. 2015. View Article : Google Scholar : PubMed/NCBI
39	Green JP, Souilhol C, Xanthis I, Martinez-Campesino L, Bowden NP, Evans PC and Wilson HL: Atheroprone flow activates inflammation via endothelial ATP-dependent P2X7-p38 signalling. Cardiovasc Res. 114:324–335. 2018. View Article : Google Scholar :
40	Larrick JW, Hirata M, Balint RF, Lee J, Zhong J and Wright SC: Human CAP18: A novel antimicrobial lipopolysaccha-ride-binding protein. Infect Immun. 63:1291–1297. 1995.PubMed/NCBI
41	Hu Z, Murakami T, Suzuki K, Tamura H, Kuwahara-Arai K, Iba T and Nagaoka I: Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism. PLoS One. 9:e857652014. View Article : Google Scholar : PubMed/NCBI
42	Suzuki K, Murakami T, Kuwahara-Arai K, Tamura H, Hiramatsu K and Nagaoka I: Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells. Int Immunol. 23:185–193. 2011. View Article : Google Scholar : PubMed/NCBI